Respiratory
GLP-1 receptor agonists and obstructive sleep apnoea: what this study means for primary care
A large US matched cohort found lower recorded cerebrovascular, hospital-use and mortality outcomes among people with OSA exposed to GLP-1 receptor agonists. The finding is promising, but observational and not a replacement for standard OSA care.
Medicine Central Editorial Teamabout 12 hours ago · 5 min read
